We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Guidelines for Percutaneous Coronary Interventions

By HospiMedica staff writers
Posted on 04 May 2005
The European Society of Cardiology (ESC, Sophia Antipolis, France) has released its Guidelines on Percutaneous Coronary Interventions (PCI). More...


According to these guidelines, PCI can be regarded as the first option for a larger group of patients with acute coronary syndromes than before, since recent improvements have made PCI a procedure that can be safely and effectively applied to patients with various types of coronary lesions and patients with and without myocardial infarction. The new guidelines represent the consensus of a Task Force of European experts, chaired by Professor Sigmund Silbur of the Gemeinschaftspraxis Hospital (Munich, Germany).

One highlight of the guidelines is that thrombolysis for a heart attack can be administered within the first three hours after onset of chest pain, if no catheter lab is accessible, preferably within 90 minutes. Thrombolysis should be followed by invasive diagnosis and treatment, if applicable.

Because of differences in infrastructure between Europe and the United States, the guidelines differ from U.S. guidelines when addressing issues of time and distance to catheter laboratories. European guidelines are based on the likelihood that most patients can reach a catheter lab within 90 minutes after first medical contact. Also, the ESC guidelines do not demand on-cite cardiac surgery for PCI, since so many more hospitals are in a position to offer high-quality PCI.

"The field of PCI is constantly and rapidly evolving,” explained Professor Silber. "We are always waiting for the next study and development. Following each new study, we need to re-evaluate our thinking and clinical practice.” The guidelines are available on the ESC website (www.escardio.org).




Related Links:
European Society of Cardiology

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.